Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs
Clinical trial NCT01405053 · COMPLETED
Trial details
- NCT number
- NCT01405053
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-16
- Primary completion
- 2015-11-02
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.